Imagine you are the Quality Director of a site manufacturing critical medicinal products or medical devices. You have a sickness absence rate of 50% of QA and QC staff. The government is keen for the site to produce as much product as possible. You need to develop a plan to keep the site in compliance whilst freeing up resources to help with daily QA/QC activities. Activities can be STOPPED, DELAYED or CONTINUED.
NSF's white paper, written by Lynne Byers, explains how to maintain site manufacturing activities and stay in compliance when staff numbers have been significantly reduced. Find out which activities should be continued, delayed or stopped and how to make these changes using the quality system.
Click here to download.
